Hemodialysis Equipment Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	159 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19224333

Best Price Guarantee
Price	from $4,850
Length	159 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19224333

Hemodialysis Equipment Market

Growth Factors of Hemodialysis Equipment Market

The hemodialysis equipment market size was valued at USD 14.12 billion in 2023, and the market is now projected to grow from USD 14.67 billion in 2024 to USD 26.31 billion by 2032, exhibiting a CAGR of 7.6% during the forecast period of 2023-2032.

Government has put restrictions on social gatherings, events and moving out from home which make the people homesick. Numerous companies are encountering hurdles due to covid pandemic as the outbreak situation has curtailed production and supply chain which has hindered the market switched to treating covid patients as priority over the other procedures which led the hemodialysis equipment market growth.

Growing chronic kidney disease prevalence will fuel market expansion during projected period. The main cause propelling the increasing global adoption of hemodialysis equipment is the rapidly rising prevalence of kidney ailments, including chronic kidney diseases and kidney failure. Market Growth is Boosted by Increasing Clinical Activities for the Introduction of Technologically Advanced Products. The increasing frequency of various kidney-related problems, including as end-stage renal diseases and chronic kidney diseases, has led healthcare providers to expand their research and development activities to adopt technologically improved equipment.

Increasing home-based modality adoption to accelerate hemodialysis equipment market growth during projected period. Worldwide, the number of patients in need of renal replacement therapies (RRTs) is rising, and many of these people pass away too soon as a result of not having access to treatment. Hemodialysis performed in centers is the most widely used treatment worldwide. Unfortunately, a lot of patients find it inappropriate because of their weak health, wasted time traveling, and ambulation issues. Consequently, these patients find home dialysis machines to be more appropriate. Furthermore, a number of manufacturers have been able to expand their clinical research efforts in order to introduce home-based devices due to the increased awareness of the advantages of home-based modalities.

Comprehensive Analysis of Hemodialysis Equipment Market

The hemodialysis equipment market and healthcare industry is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessments considering the dominant supply and demand forces that impact the pharmacy benefit management industry. These segmentations are methodically segregated by product and by end users. The product segmentations include, Hemodialysis Machines segmentations include In-center Hemodialysis Machines and Home-Based Hemodialysis Machines and Hemodialysis Consumables (Dialyzers, Dialysate, Access Products, and Others)), while by End-user segmentations include Dialysis Center & Hospital and Home Healthcare.

The North America region lead the hemodialysis equipment market by benefitting a market size of USD 5.40 billion in 2023 due to increasing number of people with kidney diseases, increasing number of patients seeking diagnosis and treatment, strong presence of major players in the market, quick adoption of home-based hemodialysis machines, and introduction of state-of-the-art technology in equipment.

The top players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, Fresenius Medical Care AG & Co. KGaA (Germany), Baxter (U.S.), B. Braun SE (Germany), NIPRO (Japan), Nikkiso Co., Ltd. (Japan), Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation) (Japan), Medtronic (Ireland), Kimal (U.K.) these market players provide a level-playing competitive landscape.

In September 2023, Versi HD with GuideMe Software, a fully redesigned self-guided interface for the company's Versi HD chronic home hemodialysis (HHD) system, has received FDA clearance, according to a statement released by Fresenius Medical Care.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Growth Rate CAGR of 7.6% from 2024-2032

Unit Value (USD Billion)

Segmentation By Product

Hemodialysis Machines
In-center Hemodialysis Machines
Home-Based Hemodialysis Machines
Hemodialysis Consumables
Dialyzers
Dialysate
Access products
Others

By End-user

Dialysis Center & Hospital
Home Healthcare

By Region

North America (By Product, End-user, and Country)
U.S.
Canada
Europe (By Product, End-user, and Country/Sub-Region)
U.K.
Germany
France
Italy
Spain
Scandinavia
Rest of Europe
Asia-Pacific (By Product, End-user, and Country/Sub-Region)
Japan
China
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America (By Product, End-user, and Country/Sub-Region)
Brazil
Mexico
Rest of Latin America
Middle East & Africa ( By Product, End-user, and Country/Sub-Region)
GCC
South Africa
Rest of the Middle East & Africa

Please Note: It will take 5-6 business days to complete the report upon order confirmation.

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Prevalence of Chronic Kidney Diseases, By Key Region/Countries, 2022/ 2023; 4.2. Overview of Dialysis Service Providers; 4.3. New Product Launches, By Key Players; 4.4. Key Industry Developments - Mergers, Acquisitions and Partnerships; 4.5. Impact of COVID-19 on the Market
5. Global Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. Hemodialysis Machines; 5.1.1.1. In-center Hemodialysis Machines; 5.1.1.2. Home-Based Hemodialysis Machines; 5.1.2. Hemodialysis Consumables; 5.1.2.1. Dialyzers; 5.1.2.2. Dialysate; 5.1.2.3. Access products; 5.1.2.4. Others; 5.2. Market Analysis, Insights and Forecast – By End-user; 5.2.1. Dialysis Centre & Hospital; 5.2.2. Home Healthcare; 5.3. Market Analysis, Insights and Forecast – By Region; 5.3.1. North America; 5.3.2. Europe; 5.3.3. Asia Pacific; 5.3.4. Latin America; 5.3.5. Middle East & Africa
6. North America Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. Hemodialysis Machines; 6.1.1.1. In-center Hemodialysis Machines; 6.1.1.2. Home-Based Hemodialysis Machines; 6.1.2. Hemodialysis Consumables; 6.1.2.1. Dialyzers; 6.1.2.2. Dialysate; 6.1.2.3. Access products; 6.1.2.4. Others; 6.2. Market Analysis, Insights and Forecast – By End-user; 6.2.1. Dialysis Centre & Hospital; 6.2.2. Home Healthcare; 6.3. Market Analysis – By Country/Sub-region; 6.3.1. U.S.; 6.3.2. Canada
7. Europe Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. Hemodialysis Machines; 7.1.1.1. In-center Hemodialysis Machines; 7.1.1.2. Home-Based Hemodialysis Machines; 7.1.2. Hemodialysis Consumables; 7.1.2.1. Dialyzers; 7.1.2.2. Dialysate; 7.1.2.3. Access products; 7.1.2.4. Others; 7.2. Market Analysis, Insights and Forecast – By End-user; 7.2.1. Dialysis Centre & Hospital; 7.2.2. Home Healthcare; 7.3. Market Analysis – By Country/ Sub-Region; 7.3.1. U.K.; 7.3.2. Germany; 7.3.3. France; 7.3.4. Spain; 7.3.5. Italy; 7.3.6. Scandinavia; 7.3.7. Rest of Europe
8. Asia Pacific Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. Hemodialysis Machines; 8.1.1.1. In-center Hemodialysis Machines; 8.1.1.2. Home-Based Hemodialysis Machines; 8.1.2. Hemodialysis Consumables; 8.1.2.1. Dialyzers; 8.1.2.2. Dialysate; 8.1.2.3. Access products; 8.1.2.4. Others; 8.2. Market Analysis, Insights and Forecast – By End-user; 8.2.1. Dialysis Centre & Hospital; 8.2.2. Home Healthcare; 8.3. Market Analysis – By Country/ Sub-Region; 8.3.1. Japan; 8.3.2. China; 8.3.3. India; 8.3.4. Australia; 8.3.5. Southeast Asia; 8.3.6. Rest of Asia Pacific
9. Latin America Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. Hemodialysis Machines; 9.1.1.1. In-center Hemodialysis Machines; 9.1.1.2. Home-Based Hemodialysis Machines; 9.1.2. Hemodialysis Consumables; 9.1.2.1. Dialyzers; 9.1.2.2. Dialysate; 9.1.2.3. Access products; 9.1.2.4. Others; 9.2. Market Analysis, Insights and Forecast – By End-user; 9.2.1. Dialysis Centre & Hospital; 9.2.2. Home Healthcare; 9.3. Market Analysis – By Country/ Sub-Region; 9.3.1. Brazil; 9.3.2. Mexico; 9.3.3. Rest of Latin America
10. Middle East & Africa Hemodialysis Equipment Market Analysis, Insights and Forecast, 2019-2032: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. Hemodialysis Machines; 10.1.1.1. In-center Hemodialysis Machines; 10.1.1.2. Home-Based Hemodialysis Machines; 10.1.2. Hemodialysis Consumables; 10.1.2.1. Dialyzers; 10.1.2.2. Dialysate; 10.1.2.3. Access products; 10.1.2.4. Others; 10.2. Market Analysis, Insights and Forecast – By End-user; 10.2.1. Dialysis Centre & Hospital; 10.2.2. Home Healthcare; 10.3. Market Analysis – By Country/ Sub-Region; 10.3.1. GCC Countries; 10.3.2. South Africa; 10.3.3. Rest of Middle East & Africa
11. Competitive Analysis: 11.1. Global Market Share Analysis (2023); 11.2. Company Profiles; 11.2.1. Fresenius Medical Care AG & Co. KGaA; 11.2.1.1. Overview; 11.2.1.2. Products; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. Financials (Based On Availability); 11.2.2. Baxter; 11.2.2.1. Overview; 11.2.2.2. Products; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. Financials (Based On Availability); 11.2.3. B. Braun SE; 11.2.3.1. Overview; 11.2.3.2. Products; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. Financials (Based On Availability); 11.2.4. NIPRO; 11.2.4.1. Overview; 11.2.4.2. Products; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. Financials (Based On Availability); 11.2.5. Nikkiso Co., Ltd.; 11.2.5.1. Overview; 11.2.5.2. Products; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. Financials (Based On Availability); 11.2.6. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation); 11.2.6.1. Overview; 11.2.6.2. Products; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. Financials (Based On Availability); 11.2.7. Medtronic; 11.2.7.1. Overview; 11.2.7.2. Products; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. Financials (Based On Availability); 11.2.8. Kimal; 11.2.8.1. Overview; 11.2.8.2. Products; 11.2.8.3. SWOT Analysis; 11.2.8.4. Recent Developments; 11.2.8.5. Strategies; 11.2.8.6. Financials (Based On Availability)